160 related articles for article (PubMed ID: 20064474)
1. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
Brahmakshatriya VR; Lupiani B; Reddy SM
Vaccine; 2010 Mar; 28(12):2388-96. PubMed ID: 20064474
[TBL] [Abstract][Full Text] [Related]
2. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
Lee CW; Senne DA; Suarez DL
Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus.
Avellaneda G; Mundt E; Lee CW; Jadhao S; Suarez DL
Avian Dis; 2010 Mar; 54(1 Suppl):278-86. PubMed ID: 20521645
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens.
Zhao S; Jin M; Li H; Tan Y; Wang G; Zhang R; Chen H
Avian Dis; 2005 Dec; 49(4):488-93. PubMed ID: 16404988
[TBL] [Abstract][Full Text] [Related]
6. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.
James CM; Foong YY; Mansfield JP; Fenwick SG; Ellis TM
Vaccine; 2007 Aug; 25(31):5892-901. PubMed ID: 17583393
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.
Tumpey TM; Alvarez R; Swayne DE; Suarez DL
J Clin Microbiol; 2005 Feb; 43(2):676-83. PubMed ID: 15695663
[TBL] [Abstract][Full Text] [Related]
8. Overview of avian influenza DIVA test strategies.
Suarez DL
Biologicals; 2005 Dec; 33(4):221-6. PubMed ID: 16257543
[TBL] [Abstract][Full Text] [Related]
9. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
10. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
12. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
14. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
15. [Rescued influenza A virus with codon deoptimized NS1 gene is attenuated both in vitro and in vivo].
Luan S; Pan W; Li T; Yang H; Zhang B; Li F; Chen L
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):720-6. PubMed ID: 19670641
[TBL] [Abstract][Full Text] [Related]
16. Progressive truncation of the Non-Structural 1 gene of H7N1 avian influenza viruses following extensive circulation in poultry.
Dundon WG; Milani A; Cattoli G; Capua I
Virus Res; 2006 Aug; 119(2):171-6. PubMed ID: 16464514
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
18. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
[TBL] [Abstract][Full Text] [Related]
19. Detection of highly pathogenic avian influenza virus infection in vaccinated chicken flocks by monitoring antibodies against non-structural protein 1 (NS1).
Takeyama N; Minari K; Kajihara M; Isoda N; Sakamoto R; Sasaki T; Kokumai N; Takikawa N; Shiraishi R; Mase M; Hagiwara J; Kodama T; Imamura T; Sakaguchi M; Ohgitani T; Sawata A; Okamatsu M; Muramatsu M; Tsukamoto K; Lin Z; Tuchiya K; Sakoda Y; Kida H
Vet Microbiol; 2011 Jan; 147(3-4):283-91. PubMed ID: 20673616
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
Jang H; Elaish M; Kc M; Abundo MC; Ghorbani A; Ngunjiri JM; Lee CW
PLoS One; 2018; 13(4):e0195285. PubMed ID: 29624615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
